During the past decade, Kaiser Permanente Washington conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 78 clinical trials were completed, i.e. on average, 84.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 56 clinical trials were completed. i.e. 430.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Washington" #1 sponsor was "National Cancer Institute (NCI)" with 83 trials, followed by "SWOG Cancer Research Network" with 21 trials sponsored, "Alliance for Clinical Trials in Oncology" with 18 trials sponsored, "Kaiser Permanente" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Washington" #1 collaborator was "National Cancer Institute (NCI)" with 58 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Washington" are "Recurrent Ovarian Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (8 trials), "Recurrent Fallopian Tube Carcinoma" (7 trials), "Recurrent Primary Peritoneal Carcinoma" (7 trials) and "Recurrent Squamous Cell Lung Carcinoma" (7 trials). Many other conditions were trialed in "Kaiser Permanente Washington" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Washington" are "Drug" (116 trials), "Other" (107 trials), "Biological" (61 trials), "Procedure" (31 trials) and "Radiation" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (69 trials), "Quality-of-Life Assessment" (37 trials), "Paclitaxel" (19 trials), "Carboplatin" (17 trials) and "Questionnaire Administration" (16 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Washington" are 117 trials for "All" genders and 34 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente Washington". undefined are not yet recruiting, 18 are recruiting, 90 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Kaiser Permanente Washington, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Washington, 7 "Phase 1" clinical trials were conducted, 66 "Phase 2" clinical trials and 76 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".